Cargando…

Multiple pathogens and prostate cancer

BACKGROUND: The aim of this review is to consider whether multiple pathogens have roles in prostate cancer. METHODS: We have reviewed case control studies in which infectious pathogens in prostate cancer were compared to normal and benign prostate tissues. We also reviewed additional evidence from r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawson, James S., Glenn, Wendy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150368/
https://www.ncbi.nlm.nih.gov/pubmed/35637508
http://dx.doi.org/10.1186/s13027-022-00427-1
_version_ 1784717401727696896
author Lawson, James S.
Glenn, Wendy K.
author_facet Lawson, James S.
Glenn, Wendy K.
author_sort Lawson, James S.
collection PubMed
description BACKGROUND: The aim of this review is to consider whether multiple pathogens have roles in prostate cancer. METHODS: We have reviewed case control studies in which infectious pathogens in prostate cancer were compared to normal and benign prostate tissues. We also reviewed additional evidence from relevant published articles. RESULTS: We confirmed that high risk human papilloma viruses are a probable cause of prostate cancer. We judged Escherichia coli, Cutibacterium acnes, Neisseria gonorrhoea, Herpes simplex, Epstein Barr virus and Mycoplasmas as each having possible but unproven roles in chronic prostatic inflammation and prostate cancer. We judged Cytomegalovirus, Chlamydia trachomatis, Trichomonas vaginalis and the Polyoma viruses as possible but unlikely to have a role in prostate cancer. CONCLUSIONS AND ACTIONS: The most influential cause of prostate cancer appears to be infection induced chronic inflammation. Given the high prevalence of prostate cancer it is important for action to can be taken without waiting for additional conclusive evidence. These include: 1. Encouragement of all boys (as well as girls) to have HPV vaccines. 2. The vigorous use of antibiotics to treat all bacterial pathogens identified in the urogenital tract. 3. The use of antiviral medications to control herpes infections. 4. Education about safe sexual practices.
format Online
Article
Text
id pubmed-9150368
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91503682022-05-31 Multiple pathogens and prostate cancer Lawson, James S. Glenn, Wendy K. Infect Agent Cancer Review BACKGROUND: The aim of this review is to consider whether multiple pathogens have roles in prostate cancer. METHODS: We have reviewed case control studies in which infectious pathogens in prostate cancer were compared to normal and benign prostate tissues. We also reviewed additional evidence from relevant published articles. RESULTS: We confirmed that high risk human papilloma viruses are a probable cause of prostate cancer. We judged Escherichia coli, Cutibacterium acnes, Neisseria gonorrhoea, Herpes simplex, Epstein Barr virus and Mycoplasmas as each having possible but unproven roles in chronic prostatic inflammation and prostate cancer. We judged Cytomegalovirus, Chlamydia trachomatis, Trichomonas vaginalis and the Polyoma viruses as possible but unlikely to have a role in prostate cancer. CONCLUSIONS AND ACTIONS: The most influential cause of prostate cancer appears to be infection induced chronic inflammation. Given the high prevalence of prostate cancer it is important for action to can be taken without waiting for additional conclusive evidence. These include: 1. Encouragement of all boys (as well as girls) to have HPV vaccines. 2. The vigorous use of antibiotics to treat all bacterial pathogens identified in the urogenital tract. 3. The use of antiviral medications to control herpes infections. 4. Education about safe sexual practices. BioMed Central 2022-05-30 /pmc/articles/PMC9150368/ /pubmed/35637508 http://dx.doi.org/10.1186/s13027-022-00427-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Lawson, James S.
Glenn, Wendy K.
Multiple pathogens and prostate cancer
title Multiple pathogens and prostate cancer
title_full Multiple pathogens and prostate cancer
title_fullStr Multiple pathogens and prostate cancer
title_full_unstemmed Multiple pathogens and prostate cancer
title_short Multiple pathogens and prostate cancer
title_sort multiple pathogens and prostate cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150368/
https://www.ncbi.nlm.nih.gov/pubmed/35637508
http://dx.doi.org/10.1186/s13027-022-00427-1
work_keys_str_mv AT lawsonjamess multiplepathogensandprostatecancer
AT glennwendyk multiplepathogensandprostatecancer